Apply on Employer Site

MD Anderson Cancer Center · 1 month ago

Postdoctoral Fellow - Leukemia - Research

Houston, TX

Full-time

Onsite

New Grad

$64K/yr - $76K/yr

MD Anderson Cancer Center is a leading institution in cancer research, and they are seeking a highly motivated postdoctoral fellow to lead a project focused on drug-resistant leukemias. The role involves conducting research on cell death pathways, drug resistance mechanisms, and developing innovative strategies for molecular targeting in leukemia treatment.

Health CareHealth DiagnosticsHospitalMedical

Growth Opportunities

Responsibilities

Conduct research on cell death and cell survival pathways, as well as mechanisms of drug resistance in myeloid leukemia stem cells

Use molecular biology methodologies including gene editing, mutation detection, gene and protein expression analysis, and chromatin accessibility profiling

Evaluate responses to drug treatments in both in vitro and in vivo leukemia cell systems

Collaborate with established investigators in interdisciplinary projects involving various laboratory techniques

Write reports on scientific results and present findings in meetings and conferences

Qualification

Hematologic malignanciesCell biologyMolecular biologyCancer biologyGene editingFlow cytometryMolecular cloningDrug treatmentCell death assaysData analyticsScientific collaborationTraining studentsFirst-author publicationsCommunication

Required

M.D. and/or Ph.D. degree

Expertise in cell, molecular, and cancer biology

Strong practical background and comprehensive knowledge of cell death pathways and cell signaling

Proficiency in laboratory techniques, including cell culture, drug treatment, and cell death assays

Molecular cloning

Flow cytometry

Experience with murine models of leukemia

Data analytic skills using innovative analytical approaches

Excellent written and spoken English communication skills

One or more first-author publications in high-impact, peer-reviewed journals in the field of hematology

Benefits

Medical

Dental

Paid time off

Retirement

Tuition benefits

Educational opportunities

Individual and team recognition

Company

MD Anderson Cancer Center

Glassdoor4.1

MD Anderson Cancer Center is a cancer treatment and research institution which gives treatment, and research of all types of cancer.

Founded in 1994

Houston, Texas, USA

10001+ employees

https://www.mdanderson.org/

Funding

Current Stage

Late Stage

Total Funding

$16.2M

Key Investors

Break Through CancerGastro-Intestinal Research Foundation

2023-05-16Grant· $2.7M

2023-01-24Grant· $3.5M

2022-04-19Grant· $10M

Leadership Team

David Tweardy

Professor

Recent News

GlobeNewswire

Automated and Closed Cell Therapy Processing Systems Market Report 2026-2031: Analysis by Workflow, Type, Scale and Region

2026-01-23

GlobeNewswire

IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems

2026-01-19

Medical Xpress - latest medical and health news stories

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

2026-01-17

Company data provided by crunchbase